World: Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter✕

Date Range

Sector

BriaCell Therapeutics (BCT:CC)

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Phase 3 Bria-IMT Study Enrollment Surpasses 230 Patients

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Therapeutics: Redefining Oncology with Personalized Cancer Immunotherapy

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

biotech investing
InMed Pharmaceuticals (INM)

InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer

biotech investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Amends Preferred Investment Options

pharmaceutical investing
Seegnal (SEGN:CA)

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

biotech investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

pharmaceutical investing

Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

InMed Pharmaceuticals (INM)

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

biotech investing
InMed Pharmaceuticals (INM)

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

biotech investing
Seegnal (SEGN:CA)

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

biotech investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports First Quarter 2026 Results and Highlights

psychedelics investing

Latest press releases News

More press releases News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES